Robles, Luke A.
McGeagh, Lucy
Aning, Jonathan
Bahl, Amit
Challapalli, Amarnath
Koupparis, Anthony
Persad, Raj
Rowe, Edward
Shiridzinomwa, Constance
Martin, Richard M.
Lane, J. Athene https://orcid.org/0000-0002-7578-4925
Funding for this research was provided by:
NIHR Bristol Biomedical Research Centre
Article History
Received: 16 July 2024
Accepted: 7 May 2025
First Online: 24 May 2025
Declarations
:
: NHS ethical approval was granted by the Wales REC 1 Ethics Committee on 23rd April 2018 in addition to the Health Research Authority. Formal confirmation of the capacity and capability to deliver the study were provided from the local NHS Research & Development department. The trial is being conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, 1996; the principles of Good Clinical Practice, The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent amendments, the Human Tissue Act 2004, and the Department of Health Research Governance Framework for Health and Social Care, 2005.
: Not applicable.
: The authors declare that they have no competing interests.